177 related articles for article (PubMed ID: 31597844)
1. New developments in the treatment of follicular lymphoma.
Leonard JP
Rinsho Ketsueki; 2019; 60(9):1199-1204. PubMed ID: 31597844
[TBL] [Abstract][Full Text] [Related]
2. Where to start? Upfront therapy for follicular lymphoma in 2018.
Leonard JP; Nastoupil LJ; Flowers CR
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):185-188. PubMed ID: 30504308
[TBL] [Abstract][Full Text] [Related]
3. Obinutuzumab in follicular lymphoma.
Martinez-Calle N; Figueroa-Mora R; Villar-Fernandez S; Marcos-Jubilar M; Panizo C
Drugs Today (Barc); 2016 Dec; 52(12):643-651. PubMed ID: 28276536
[TBL] [Abstract][Full Text] [Related]
4. An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma.
Falchi L; Ferrajoli A; Jacobs I; Nava-Parada P
Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):508-518.e14. PubMed ID: 29934061
[TBL] [Abstract][Full Text] [Related]
5. Obinutuzumab: A Review in Rituximab-Refractory or -Relapsed Follicular Lymphoma.
Dhillon S
Target Oncol; 2017 Apr; 12(2):255-262. PubMed ID: 28324270
[TBL] [Abstract][Full Text] [Related]
6. Advancements in the Management of Follicular Lymphoma: A Comprehensive Review.
Merryman R; Mehtap Ö; LaCasce A
Turk J Haematol; 2024 May; 41(2):69-82. PubMed ID: 38660754
[TBL] [Abstract][Full Text] [Related]
7. Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma.
Jacobson CA; Freedman AS
Curr Hematol Malig Rep; 2016 Jun; 11(3):218-23. PubMed ID: 26995595
[TBL] [Abstract][Full Text] [Related]
8. The role of obinutuzumab in the management of follicular lymphoma.
O'Nions J; Townsend W
Future Oncol; 2019 Nov; 15(31):3565-3578. PubMed ID: 31538821
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US.
Guzauskas GF; Masaquel A; Reyes C; Bernaards C; Krivasi T; Veenstra DL
J Med Econ; 2018 Oct; 21(10):960-967. PubMed ID: 29898619
[TBL] [Abstract][Full Text] [Related]
10. Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy.
Rogers LM; Mott SL; Smith BJ; Link BK; Sahin D; Weiner GJ
Clin Cancer Res; 2017 Feb; 23(4):954-961. PubMed ID: 27528699
[No Abstract] [Full Text] [Related]
11. Treating relapsed follicular lymphoma.
Erblich T; Montoto S
Expert Rev Hematol; 2018 May; 11(5):403-410. PubMed ID: 29542329
[TBL] [Abstract][Full Text] [Related]
12. Follicular lymphoma: 2020 update on diagnosis and management.
Freedman A; Jacobsen E
Am J Hematol; 2020 Mar; 95(3):316-327. PubMed ID: 31814159
[TBL] [Abstract][Full Text] [Related]
13. Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E
Am J Hematol; 2022 Dec; 97(12):1638-1651. PubMed ID: 36255040
[TBL] [Abstract][Full Text] [Related]
14. Targeted Therapies for Follicular Lymphoma.
Girard J; Karimi Y; Carty S; Wilcox R; Kaminiski M; Malek S; Phillips T
Curr Hematol Malig Rep; 2021 Feb; 16(1):25-31. PubMed ID: 33754292
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD20 antibody therapy is highly effective in the treatment of follicular lymphoma.
Marshall H
Trends Immunol; 2001 Apr; 22(4):183-4. PubMed ID: 11274916
[No Abstract] [Full Text] [Related]
16. Novel immunotherapy approaches to follicular lymphoma.
Flowers CR; Leonard JP; Nastoupil LJ
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):194-199. PubMed ID: 30504310
[TBL] [Abstract][Full Text] [Related]
17. Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.
Sehn LH; Goy A; Offner FC; Martinelli G; Caballero MD; Gadeberg O; Baetz T; Zelenetz AD; Gaidano G; Fayad LE; Buckstein R; Friedberg JW; Crump M; Jaksic B; Zinzani PL; Padmanabhan Iyer S; Sahin D; Chai A; Fingerle-Rowson G; Press OW
J Clin Oncol; 2015 Oct; 33(30):3467-74. PubMed ID: 26282650
[TBL] [Abstract][Full Text] [Related]
18. Lenalidomide in follicular lymphoma.
Flowers CR; Leonard JP; Fowler NH
Blood; 2020 Jun; 135(24):2133-2136. PubMed ID: 32236519
[TBL] [Abstract][Full Text] [Related]
19. An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date.
Yilmaz U; Salihoglu A; Soysal T
Drug Des Devel Ther; 2021; 15():3809-3820. PubMed ID: 34522085
[TBL] [Abstract][Full Text] [Related]
20. Treatment of follicular lymphoma: current status.
Tilly H; Zelenetz A
Leuk Lymphoma; 2008; 49 Suppl 1():7-17. PubMed ID: 18821428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]